CDC Notice of Intent to Sole Source for Inhalation Support / TSI MOUDI-II Instrument

OFR Combined SAP SOW & Evaluation Template – July 2013 Statement of Work Title: TSI MOUDI-II SECTION 1 – BACKGROUND TSI Inc., is US-based instrument manufacturer supplying high performance laboratory instrumentation to government, industry, commercial laboratories, and research institutions. TSI Incorporated holds ISO 9001:2015 certification for its quality management system at its Shoreview, Minnesota, headquarters. The ability to measure particles over a large range of sizes is essential in our research, especially when examining inhalable particle sizes and their possible health effects. This procurement of a 10 stage Micro Orifice Uniform Deposit Impactor (MOUDI) helps laboratorians pursue gold standard science, study toxins more effectively, and deepens our understanding of how these particles impact health. SECTION 2 – PURPOSE This request is for the purchase of a 10 stage Micro Orifice Uniform Deposit Impactor (MOUDI) Particle Sizer. The instrument will allow Health Effects Laboratory Division, Physical Effects Research Branch laboratorians to obtain mass based particle size distributions for test dusts and powders, droplets and collected aerosol samples over the 0.05 to 18 um size range. This wide mass based sized ranging capability is important when considering the inhalable particle size fractions and potential health effects. SECTION 3 – SCOPE OF WORK The vendor, TSI Inc., will be responsible for fulfillment of the order, packing and shipping all items to the NIOSH Morgantown campus located at 1095 Willowdale Road, Morgantown, WV, 26505. This instrument does not connect to a computer, and it does not generate digital data. The 10 impactor stages have disposable foil collection plates that are weighed pre and post sample collection by existing laboratory scales. Additionally, disposable membrane filters can be used on the stages to collect particles for viewing with the existing NIOSH Scanning Electron Microscope. SECTION 4 – TASKS TO BE PERFORMED Health Effects Laboratory Division, Physical Effects Research Branch laboratory personnel will set the MOUDI up to research specifications in a NIOSH Morgantown laboratory. SECTION 5 – GOVERNMENT FURNISHED MATERIALS An existing instrument cart will be used, and an existing micro balance scale will be used to measure total particle weights on the 10 stages. An existing laboratory sample pump will be used to provide 30 L/min of air flow. SECTION 6 – PERIOD OF PERFORMANCE - Date of delivery 06/01/2026 – 05/31/2027. SECTION 7 – PLACE OF PERFORMANCE NIOSH Morgantown: 1095 Willowdale Road, Building L, Mail Stop 2027, Morgantown, WV, 26505 – Laboratory 3614. SECTION 8 – DELIVERABLES/REPORTING SCHEDULE -- 1 of 4 -- OFR Combined SAP SOW & Evaluation Template – July 2013 Items Description Quantity or No. of Copies Delivery Date Deliver To MOUDI-II Sizes particles from 0.05 to 18 um, based on mass. 1 06/01/2026 Walter McKiney NIOSH/HELD/PERB . Shipping Shipping cost to NIOSH Morgantown 1 06/01/2026 Walter McKiney NIOSH/HELD/PERB SECTION 9 – TRAVEL N/A SECTION 10 – SPECIAL REQUIREMENTS Section 508 and Accessibility Requirements Part A – Provision Reference HHSAR 352.239-73[8] Electronic Information and [Communication] Technology Accessibility Notice. [(Deviation)] [(a) Any offeror responding to this solicitation must comply with established HHS Information and Communication Technology (ICT) accessibility standards. Information about Section 508 is available at https://www.hhs.gov/web/section-508/index.html. (b) The Section 508 accessibility standards applicable to this solicitation are stated in the clause at 352.239-79 Information and Communication Technology Accessibility. In order to facilitate the Government’s determination whether proposed ICT supplies, products, platforms, information, and documentation meet applicable Section 508 accessibility standards, offerors must submit an appropriate HHS Section 508 Accessibility Conformance Checklist (see https://www.hhs.gov/web/section-508/accessibility-checklists/index.html) or an Accessibility Conformance Report (ACR) (based on the Voluntary Product Accessibility Template (VPAT) see https://www.itic.org/policy/accessibility/vpat), in accordance with the completion instructions. The purpose of the checklists and conformance reports are to assist HHS acquisition and program officials in determining whether proposed ICT supplies, products, platforms, information, and documentation conform to applicable Section 508 accessibility standards. Checklists and ACRs evaluate—in detail—whether the ICT conforms to specific Section 508 accessibility standards and identifies remediation efforts needed to address conformance issues. (c) If an offeror claims its supplies or services meet applicable Section 508 accessibility standards, and it is later determined by the Government, i.e., after award of a contract or order, that supplies, products, platforms, information, documentation, or services support delivered do not conform to the described accessibility standards, remediation of the supplies, products, platforms, information, documentation, or services support to the level of conformance specified in the contract will be the responsibility of the Contractor at its expense. (d) In order to facilitate the Government's determination whether proposed ICT supplies meet applicable Section 508 accessibility standards, offerors must submit an Accessibility Conformance Report, in accordance with its completion instructions and tailored to the requirements in the solicitation. The purpose of the Report is to assist HHS acquisition and program officials in determining whether proposed ICT supplies conform to applicable Section 508 accessibility standards. The template allows offerors or developers to self-evaluate their supplies and document, in detail, whether they conform to a specific Section 508 accessibility standard, and any underway remediation efforts addressing conformance issues. Instructions for pr…